710-1368

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-10-23

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild DELUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-26 (study day 155.0); relationship: REMOTE

severe assessed

Severe HIP FRACTURE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-25 (study day 64.0); relationship: NONE; serious criteria: hospitalization

severe assessed

Severe HIP FRACTURE — outcome: RECOVERED/RESOLVED; onset 2013-12-25 (study day 64.0); relationship: NONE; serious criteria: hospitalization

mild assessed

Mild PSYCHOMOTOR HYPERACTIVITY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-26 (study day 155.0); relationship: REMOTE

Data queries

No data queries.